US Cardiac Device Market Analysis
The higher prevalence of cardiovascular diseases has become a cause of concern for the US healthcare authorities as mortalities tend to rise and economic burden keep increasing. It is estimated that the country has around 80 Million persons living with cardiovascular diseases and the total direct cost associated with the disease is to the tune of around US$ 314 Billion. To gauge the disease burden, RNCOS’s new research, “US Cardiac Device Market Analysis”, offers comprehensive insight into the prevalence of cardiovascular diseases in the US, mortality by disease areas, number of procedures performed and their mean cost.
The market for cardiac medical devices in the US is one of the most prominent healthcare segments in the country as aging population and the demand for innovative treatment options are consistently boosting the market. We project that this lucrative market is likely to register a CAGR of around 9% during 2012-2015. In this context, the report effectively analyzes the current market size and key drivers. It also provides the forecast for the overall market and its key segments namely: cardiac rhythm management, interventional cardiology and cardiovascular surgery. In addition, it also provides the market analysis at the sub-segment level and elaborates their future position.
The report, “US Cardiac Device Market Analysis”, illustrates about the regulatory scenario for medical devices in the US and talks about the key laws that govern the sector. The report also covers an in-depth analysis of the competitive landscape with regards to cardiac medical devices in the US and broadly elaborates about the players in terms of their business description, financial performance, strengths & weaknesses and key activities. Moreover, the report provides a brief overview of the major cardiac medical device segments in which players primarily operate.
Overall, the report is an outcome of an extensive research and prudent analysis of the US cardiac medical device market that seeks to provide clients with an optimum source of knowledge and statistics on the concerned industry.
The market for cardiac medical devices in the US is one of the most prominent healthcare segments in the country as aging population and the demand for innovative treatment options are consistently boosting the market. We project that this lucrative market is likely to register a CAGR of around 9% during 2012-2015. In this context, the report effectively analyzes the current market size and key drivers. It also provides the forecast for the overall market and its key segments namely: cardiac rhythm management, interventional cardiology and cardiovascular surgery. In addition, it also provides the market analysis at the sub-segment level and elaborates their future position.
The report, “US Cardiac Device Market Analysis”, illustrates about the regulatory scenario for medical devices in the US and talks about the key laws that govern the sector. The report also covers an in-depth analysis of the competitive landscape with regards to cardiac medical devices in the US and broadly elaborates about the players in terms of their business description, financial performance, strengths & weaknesses and key activities. Moreover, the report provides a brief overview of the major cardiac medical device segments in which players primarily operate.
Overall, the report is an outcome of an extensive research and prudent analysis of the US cardiac medical device market that seeks to provide clients with an optimum source of knowledge and statistics on the concerned industry.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. US CARDIAC MEDICAL DEVICE MARKET OUTLOOK
3.1 Current and Future Analysis to 2015
3.1.1 Cardiac Rhythm Management
3.1.2 Interventional Cardiology
3.1.3 Cardiac Surgery
4. REGULATORY LANDSCAPE
5. COMPETITIVE ASSESSMENT
5.1 Boston Scientific Corporation
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Strengths & Weaknesses
5.1.4 Key Developments
5.2 Cordis Corporation
5.2.1 Business Overview
5.2.2 Strengths and Weaknesses
5.2.3 Key Developments
5.3 St. Jude Medical
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Strengths and Weaknesses
5.3.4 Key Developments
5.4 Medtronic
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Strengths and Weaknesses
5.4.4 Key Developments
5.5 C. R. Bard, Inc
5.5.1 Business Overview
5.5.2 Financial Overview
5.5.3 Strengths and Weaknesses
5.5.4 Key Developments
5.6 Edwards Lifesciences Corporation
5.6.1 Business Overview
5.6.2 Financial Overview
5.6.3 Strengths and Weaknesses
5.6.4 Key Developments
5.7 Teleflex Incorporated
5.7.1 Business Overview
5.7.2 Financial Overview
5.7.3 Strengths and Weaknesses
5.7.4 Key Developments
5.8 Zoll Medical Corporation
5.8.1 Business Overview
5.8.2 Financial Overview
5.8.3 Strengths and Weaknesses
5.8.4 Key Developments
5.9 Thoratec Corporation
5.9.1 Business Overview
5.9.2 Financial Overview
5.9.3 Strengths and Weaknesses
5.9.4 Key Developments
5.10 SonoSite, Inc.
5.10.1 Business Overview
5.10.2 Financial Overview
5.10.3 Strengths and Weaknesses
5.10.4 Key Developments
2. RESEARCH METHODOLOGY
3. US CARDIAC MEDICAL DEVICE MARKET OUTLOOK
3.1 Current and Future Analysis to 2015
3.1.1 Cardiac Rhythm Management
3.1.2 Interventional Cardiology
3.1.3 Cardiac Surgery
4. REGULATORY LANDSCAPE
5. COMPETITIVE ASSESSMENT
5.1 Boston Scientific Corporation
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Strengths & Weaknesses
5.1.4 Key Developments
5.2 Cordis Corporation
5.2.1 Business Overview
5.2.2 Strengths and Weaknesses
5.2.3 Key Developments
5.3 St. Jude Medical
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Strengths and Weaknesses
5.3.4 Key Developments
5.4 Medtronic
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Strengths and Weaknesses
5.4.4 Key Developments
5.5 C. R. Bard, Inc
5.5.1 Business Overview
5.5.2 Financial Overview
5.5.3 Strengths and Weaknesses
5.5.4 Key Developments
5.6 Edwards Lifesciences Corporation
5.6.1 Business Overview
5.6.2 Financial Overview
5.6.3 Strengths and Weaknesses
5.6.4 Key Developments
5.7 Teleflex Incorporated
5.7.1 Business Overview
5.7.2 Financial Overview
5.7.3 Strengths and Weaknesses
5.7.4 Key Developments
5.8 Zoll Medical Corporation
5.8.1 Business Overview
5.8.2 Financial Overview
5.8.3 Strengths and Weaknesses
5.8.4 Key Developments
5.9 Thoratec Corporation
5.9.1 Business Overview
5.9.2 Financial Overview
5.9.3 Strengths and Weaknesses
5.9.4 Key Developments
5.10 SonoSite, Inc.
5.10.1 Business Overview
5.10.2 Financial Overview
5.10.3 Strengths and Weaknesses
5.10.4 Key Developments
LIST OF FIGURES
Figure 3-1: Deaths from Cardiovascular Diseases (%)
Figure 3-2: Cardiac Devices Market (Billion US$), 2011-2015
Figure 3-3: Cardiac Devices Market by Segment (%), 2011
Figure 3-4: Cardiac Rhythm Management Devices Market (Billion US$), 2011-2015
Figure 3-5: Cardiac Rhythm Management Devices Market by Segment (%), 2011
Figure 3-6: Interventional Cardiology Devices Market (Billion US$), 2011-2015
Figure 3-7: Interventional Cardiology Devices Market by Segment (%), 2011
Figure 3-8: Cardiovascular Surgery Devices Market (Billion US$), 2011-2015
Figure 3-9: Cardiovascular Surgery Devices Market by Segment (%), 2011
Figure 3-1: Deaths from Cardiovascular Diseases (%)
Figure 3-2: Cardiac Devices Market (Billion US$), 2011-2015
Figure 3-3: Cardiac Devices Market by Segment (%), 2011
Figure 3-4: Cardiac Rhythm Management Devices Market (Billion US$), 2011-2015
Figure 3-5: Cardiac Rhythm Management Devices Market by Segment (%), 2011
Figure 3-6: Interventional Cardiology Devices Market (Billion US$), 2011-2015
Figure 3-7: Interventional Cardiology Devices Market by Segment (%), 2011
Figure 3-8: Cardiovascular Surgery Devices Market (Billion US$), 2011-2015
Figure 3-9: Cardiovascular Surgery Devices Market by Segment (%), 2011
LIST OF TABLES
Table 3-1: Prevalence of Cardiovascular Diseases (Million)
Table 3-2: Number of Cardiovascular Procedures and Mean Cost (US$)
Table 5-1: Boston Scientific - Key Products
Table 5-2: Boston Scientific - Financial Performance (Million US$), 2009-2011
Table 5-3: Cordis Corporation - Key Products
Table 5-4: St. Jude Medical - Key Products
Table 5-5: St. Jude Medical - Financial Performance (Million US$), 2009-2011
Table 5-6: Medtronic - Key Products
Table 5-7: Medtronic - Financial Performance (Million US$), 2009-2011
Table 5-8: C. R. Bard - Key Products
Table 5-9: C. R. Bard - Financial Performance (Million US$), 2009-2011
Table 5-10: Edwards Lifesciences Corporation - Key Products
Table 5-11: Edward LifeSciences Corporation - Financial Performance (Million US$), 2009-2011
Table 5-12: Teleflex - Key Products
Table 5-13: Teleflex - Financial Performance (Million US$), 2009-2011
Table 5-14: Zoll Medical Corporation - Key Products
Table 5-15: Zoll Medical Corporation - Financial Performance (Million US$), 2009-2011
Table 5-16: Thoratec Corporation - Key Products
Table 5-17: Thoratec Corporation - Financial Performance (Million US$), 2009-2011
Table 5-18: Sonosite - Key Products
Table 5-19: SonoSite - Financial Performance (Million US$), 2009-2011
Table 3-1: Prevalence of Cardiovascular Diseases (Million)
Table 3-2: Number of Cardiovascular Procedures and Mean Cost (US$)
Table 5-1: Boston Scientific - Key Products
Table 5-2: Boston Scientific - Financial Performance (Million US$), 2009-2011
Table 5-3: Cordis Corporation - Key Products
Table 5-4: St. Jude Medical - Key Products
Table 5-5: St. Jude Medical - Financial Performance (Million US$), 2009-2011
Table 5-6: Medtronic - Key Products
Table 5-7: Medtronic - Financial Performance (Million US$), 2009-2011
Table 5-8: C. R. Bard - Key Products
Table 5-9: C. R. Bard - Financial Performance (Million US$), 2009-2011
Table 5-10: Edwards Lifesciences Corporation - Key Products
Table 5-11: Edward LifeSciences Corporation - Financial Performance (Million US$), 2009-2011
Table 5-12: Teleflex - Key Products
Table 5-13: Teleflex - Financial Performance (Million US$), 2009-2011
Table 5-14: Zoll Medical Corporation - Key Products
Table 5-15: Zoll Medical Corporation - Financial Performance (Million US$), 2009-2011
Table 5-16: Thoratec Corporation - Key Products
Table 5-17: Thoratec Corporation - Financial Performance (Million US$), 2009-2011
Table 5-18: Sonosite - Key Products
Table 5-19: SonoSite - Financial Performance (Million US$), 2009-2011
